V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20208568 | 20077831 | 1.59 | 66.15 | Palliative (P) | 2017-08-20 | 2017-08-28 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100615101 |
| 20208571 | 20077832 | 1.7 | 75 | Palliative (P) | 2016-05-27 | 2016-06-11 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101291950 |
| 20208574 | 20077833 | 1.79 | 90.7 | Curative (C) | 2016-04-03 | 2016-04-20 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100382143 |
| 20208575 | 20077834 | 1.57 | 81.6 | Palliative (P) | 2016-08-18 | 2016-08-25 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101035233 |
| 20208583 | 20077835 | null | 91.1 | Palliative (P) | 2020-01-08 | 2020-01-09 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100731768 |
| 20208584 | 20077836 | 0 | 0 | Palliative (P) | null | 2018-05-25 | Capecitabine + Carboplatin + RT | 02 | N | DOXORUBICIN EMBOLISATION | 101271732 |
| 20208585 | 20077837 | 0 | 0 | Curative (C) | 2019-12-05 | 2019-12-12 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100687603 |
| 20208594 | 20077838 | null | 77.25 | Neo-adjuvant (N) | null | null | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100342389 |
| 20208596 | 20077839 | 1.61 | 82.6 | Palliative (P) | 2019-05-10 | 2019-05-11 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 101793557 |
| 20208603 | 20077840 | 0 | 0 | null | 2019-03-09 | 2019-03-15 | Doxorubicin chemoembolisation | N | null | DOXORUBICIN EMBOLISATION | 101328052 |
| 20208604 | 20077841 | 1.66 | 49.7 | Curative (C) | 2016-03-24 | 2016-04-09 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101312094 |
| 20208610 | 20077842 | 1.58 | 49.3 | Curative (C) | null | 2020-01-27 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 100596184 |
| 20208613 | 20077843 | null | null | Palliative (P) | 2016-11-22 | 2016-12-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100531401 |
| 20208616 | 20077844 | 0 | 0 | Palliative (P) | 2020-03-24 | 2020-04-15 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100099955 |
| 20208619 | 20077845 | null | null | Palliative (P) | 2019-10-01 | 2019-10-07 | Doxorubicin chemoembolisation | N | null | DOXORUBICIN EMBOLISATION | 100350996 |
| 20208625 | 20077846 | 1.71 | 69.7 | Palliative (P) | 2019-10-08 | 2019-10-12 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101352184 |
| 20208626 | 20077847 | 1.65 | 62.7 | Neo-adjuvant (N) | 2018-09-05 | 2018-09-12 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100966066 |
| 20208627 | 20077848 | 1.58 | 68.4 | Palliative (P) | 2018-10-18 | 2018-10-25 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100979676 |
| 20208629 | 20077849 | 1.71 | 110.7 | 03 | 2019-10-18 | 2019-11-13 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100638271 |
| 20208630 | 20077850 | null | 69.4 | Palliative (P) | 2018-08-19 | 2018-08-26 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101794192 |
| 20208633 | 20077851 | 1.77 | 93 | Curative (C) | 2017-09-25 | 2017-10-04 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101480918 |
| 20208634 | 20077852 | 1.64 | 85.1 | Palliative (P) | 2018-02-10 | 2018-02-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101786503 |
| 20208638 | 20077853 | 1.7 | 69 | Curative (C) | 2019-09-05 | 2019-09-19 | CAPECITABINE + CARBOPLATIN | 02 | Y | DOXORUBICIN EMBOLISATION | 100390106 |
| 20208642 | 20077854 | 1.69 | 100.6 | null | 2017-01-27 | 2017-02-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101633238 |
| 20208646 | 20077855 | 0 | 0 | 03 | 2018-04-19 | 2018-05-17 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101374468 |
| 20208652 | 20077856 | 1.54 | 93 | Curative (C) | 2018-09-22 | 2018-09-29 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100508897 |
| 20208653 | 20077857 | 1.68 | 71 | Palliative (P) | 2017-09-14 | 2017-09-22 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100111834 |
| 20208657 | 20077858 | 1.68 | 68.6 | null | 2015-03-13 | 2015-03-25 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100338066 |
| 20208658 | 20077859 | 1.63 | 68.1 | Curative (C) | 2018-06-20 | 2018-06-25 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101424828 |
| 20208659 | 20077860 | 1.56 | 74.2 | Curative (C) | 2017-04-18 | 2017-05-10 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101859691 |
| 20208660 | 20077861 | 0 | 0 | Palliative (P) | null | 2018-11-27 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100012847 |
| 20208661 | 20077862 | 1.72 | 63.2 | Palliative (P) | 2018-12-30 | 2019-01-13 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101106433 |
| 20208664 | 20077863 | 1.55 | 62.6 | Neo-adjuvant (N) | 2019-03-13 | 2019-03-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 100109399 |
| 20208669 | 20077864 | 1.7 | 81 | Palliative (P) | 2019-11-18 | 2019-12-04 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101401014 |
| 20208671 | 20077865 | 1.7 | 82 | Palliative (P) | 2018-01-02 | 2018-01-02 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101802665 |
| 20208672 | 20077866 | 1.6 | 76.8 | Palliative (P) | 2019-09-14 | 2019-09-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 100200188 |
| 20208673 | 20077867 | 1.6 | 54.7 | Palliative (P) | 2017-08-04 | 2017-08-21 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101552702 |
| 20208677 | 20077868 | 1.47 | 60.5 | null | 2016-05-23 | 2016-05-28 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100140312 |
| 20208678 | 20077869 | 1.54 | 76.6 | Neo-adjuvant (N) | 2019-09-17 | 2019-09-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101661073 |
| 20208682 | 20077870 | 0 | 0 | Palliative (P) | 2022-03-09 | 2022-04-15 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100156779 |
| 20208684 | 20077871 | 1.77 | 68.5 | 03 | 2017-06-11 | 2017-06-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101195154 |
| 20208686 | 20077872 | 1.78 | 51.2 | null | 2019-12-13 | 2020-01-04 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100425761 |
| 20208689 | 20077873 | 1.62 | 68.5 | Curative (C) | 2017-03-30 | 2017-04-17 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100730718 |
| 20208692 | 20077874 | 1.73 | 76.5 | Curative (C) | 2016-12-22 | 2017-01-11 | CISPLATIN + FLUOROURACIL | N | Y | CISPLATIN + FLUOROURACIL | 100019065 |
| 20208695 | 20077875 | 0 | 0 | Curative (C) | 2015-10-05 | 2015-10-30 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101813824 |
| 20208696 | 20077876 | 1.61 | 89 | Palliative (P) | 2019-08-10 | 2019-08-12 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100271341 |
| 20208698 | 20077877 | 1.63 | 60 | Palliative (P) | 2019-12-09 | 2019-12-23 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100090977 |
| 20208703 | 20077878 | 1.76 | 102 | Curative (C) | 2018-10-08 | 2018-10-14 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101134298 |
| 20208711 | 20077879 | 0 | 0 | Adjuvant (A) | 2019-08-03 | 2019-08-29 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100827969 |
| 20208717 | 20077880 | 1.74 | 59.1 | 03 | 2019-03-13 | 2019-04-01 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100968630 |